Furthermore, GPR65, identified as a lactate sensor in TAMs, detects lactate in the TME and initiates the downstream cAMP/PKA/CREB signaling pathway, promoting the release of high-mobility group box 1 (HMGB1) from TAMs and thereby accelerating tumor progression (44). Here, HMGB1 is linked to neoplasm.